From Zacks Investment Research: 2025-04-16 19:46:00

Johnson & Johnson (JNJ) and Albertsons Companies’ (ACI) stocks offer a hedge against market volatility, with both up 6% year to date. JNJ’s Q1 sales rose 2% to $21.89 billion, led by DARZALEX, exceeding estimates. Q1 earnings reached $2.77 per share, beating expectations. Albertsons’ Q4 sales were up 2% to $18.79 billion, with digital sales rising 24%. Q4 EPS of $0.46 surpassed estimates. JNJ raised full-year sales guidance to $91 billion-$91.8 billion, while lowering FY25 EPS outlook to $10.50-$10.70. Albertsons provided EPS guidance for FY26 of $2.03-$2.16. Both stocks hold a Zacks Rank #3 (Hold).



Read more at Zacks Investment Research: Buy These Defensive Stocks After Beating Earnings Expectations?: ACI, JNJ – April 16, 2025